References
Rampulla C, Corsico R, Majani U, Lodola E (1985) Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol. Respiration 47: 299–302
Robuschi M, Damonte C, Fasano W, Bianco S, Pasargiklian M (1985) Protective effect of a new β2-agonist: 1-(3-bromo-5-isoxazolyl)-2-(tert-butylamino) ethanol hydrochloride (broxaterol hydrochloride) in bronchial constriction from inhaled distilled water mist. Curr Ther Res 37: 333–341
American Thoracic Society (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136: 225–244
Weng TR, Levison H (1969) Standards of pulmonary function in children. Am Rev Respir Dis 99: 879–894
Anderson SD, Seale JP, Rosea P, et al (1976) Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Respir Dis 114: 493–500
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robuschi, M., Scuri, M., Spagnotto, S. et al. The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction. Eur J Clin Pharmacol 47, 465–466 (1995). https://doi.org/10.1007/BF00196863
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00196863